T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism

T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromuscular disorders : NMD 2009-09, Vol.19 (8), p.581-582
Hauptverfasser: Blain, A.M, Bauer, R, MacGowan, G, Greally, E, Laval, S, Bushby, K, Straub, V
Format: Artikel
Sprache:eng
Schlagworte:
Neurology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 582
container_issue 8
container_start_page 581
container_title Neuromuscular disorders : NMD
container_volume 19
creator Blain, A.M
Bauer, R
MacGowan, G
Greally, E
Laval, S
Bushby, K
Straub, V
description
doi_str_mv 10.1016/j.nmd.2009.06.123
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20708704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0960896609002806</els_id><sourcerecordid>20708704</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1804-4e5db48d0a8a0e7801db02991fbf9e8167e7e1cbf7554f481d3e4bcc76150a3d3</originalsourceid><addsrcrecordid>eNp9kU2KFTEUhQtR8Nm6AGc1cpbypn6SFILQNLY2NCjYjkMquWnzrErKJK-h1uB2XIdrMsXrkQNHFy7nHDjfqarXFBoKlL09Nn4xTQswNsAa2nZPqgMVvCNtx_qn1QFGBkSMjD2vXqR0BKADZ_xQ_bprvjRtA7y-zBn9SWUXfB1srcwDxoQ1Wos6p_21RjTepTAHj3VR_flNkoo63M-bVp4YtE479LnWKhoXli2sKn_f6mmrF-cxqjnoELPTwRkSUeOaQyTKZ3UfSu7ysnpm1Zzw1eO9qL5df7i7-kRuP3-8ubq8JZoK6EmPg5l6YUAJBcgFUDNBO47UTnZEQRlHjlRPlg9Db3tBTYf9pDVndADVme6ienPOXWP4ecKU5eKSxnlWHsMpyRY4CA59EdKzUMeQUkQr1-gWFTdJQe7Y5VEW7HLHLoHJgr143p09WBo8OIwy7VA0GlcqZ2mC-6_7_T9uPTvvtJp_4IbpGE7RFzSSytRKkF_3WfdVYQRoBbDuLwlUo7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20708704</pqid></control><display><type>article</type><title>T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Blain, A.M ; Bauer, R ; MacGowan, G ; Greally, E ; Laval, S ; Bushby, K ; Straub, V</creator><creatorcontrib>Blain, A.M ; Bauer, R ; MacGowan, G ; Greally, E ; Laval, S ; Bushby, K ; Straub, V</creatorcontrib><identifier>ISSN: 0960-8966</identifier><identifier>EISSN: 1873-2364</identifier><identifier>DOI: 10.1016/j.nmd.2009.06.123</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Neurology</subject><ispartof>Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.581-582</ispartof><rights>2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.nmd.2009.06.123$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids></links><search><creatorcontrib>Blain, A.M</creatorcontrib><creatorcontrib>Bauer, R</creatorcontrib><creatorcontrib>MacGowan, G</creatorcontrib><creatorcontrib>Greally, E</creatorcontrib><creatorcontrib>Laval, S</creatorcontrib><creatorcontrib>Bushby, K</creatorcontrib><creatorcontrib>Straub, V</creatorcontrib><title>T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism</title><title>Neuromuscular disorders : NMD</title><subject>Neurology</subject><issn>0960-8966</issn><issn>1873-2364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kU2KFTEUhQtR8Nm6AGc1cpbypn6SFILQNLY2NCjYjkMquWnzrErKJK-h1uB2XIdrMsXrkQNHFy7nHDjfqarXFBoKlL09Nn4xTQswNsAa2nZPqgMVvCNtx_qn1QFGBkSMjD2vXqR0BKADZ_xQ_bprvjRtA7y-zBn9SWUXfB1srcwDxoQ1Wos6p_21RjTepTAHj3VR_flNkoo63M-bVp4YtE479LnWKhoXli2sKn_f6mmrF-cxqjnoELPTwRkSUeOaQyTKZ3UfSu7ysnpm1Zzw1eO9qL5df7i7-kRuP3-8ubq8JZoK6EmPg5l6YUAJBcgFUDNBO47UTnZEQRlHjlRPlg9Db3tBTYf9pDVndADVme6ienPOXWP4ecKU5eKSxnlWHsMpyRY4CA59EdKzUMeQUkQr1-gWFTdJQe7Y5VEW7HLHLoHJgr143p09WBo8OIwy7VA0GlcqZ2mC-6_7_T9uPTvvtJp_4IbpGE7RFzSSytRKkF_3WfdVYQRoBbDuLwlUo7A</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Blain, A.M</creator><creator>Bauer, R</creator><creator>MacGowan, G</creator><creator>Greally, E</creator><creator>Laval, S</creator><creator>Bushby, K</creator><creator>Straub, V</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20090901</creationdate><title>T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism</title><author>Blain, A.M ; Bauer, R ; MacGowan, G ; Greally, E ; Laval, S ; Bushby, K ; Straub, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1804-4e5db48d0a8a0e7801db02991fbf9e8167e7e1cbf7554f481d3e4bcc76150a3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blain, A.M</creatorcontrib><creatorcontrib>Bauer, R</creatorcontrib><creatorcontrib>MacGowan, G</creatorcontrib><creatorcontrib>Greally, E</creatorcontrib><creatorcontrib>Laval, S</creatorcontrib><creatorcontrib>Bushby, K</creatorcontrib><creatorcontrib>Straub, V</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuromuscular disorders : NMD</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blain, A.M</au><au>Bauer, R</au><au>MacGowan, G</au><au>Greally, E</au><au>Laval, S</au><au>Bushby, K</au><au>Straub, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism</atitle><jtitle>Neuromuscular disorders : NMD</jtitle><date>2009-09-01</date><risdate>2009</risdate><volume>19</volume><issue>8</issue><spage>581</spage><epage>582</epage><pages>581-582</pages><issn>0960-8966</issn><eissn>1873-2364</eissn><pub>Elsevier B.V</pub><doi>10.1016/j.nmd.2009.06.123</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-8966
ispartof Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.581-582
issn 0960-8966
1873-2364
language eng
recordid cdi_proquest_miscellaneous_20708704
source Elsevier ScienceDirect Journals Complete
subjects Neurology
title T.P.2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A25%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T.P.2.07%20Attenuation%20of%20adverse%20effects%20of%20prednisolone%20on%20%CE%B4-sarcoglycan-deficient%20cardiomyopathy%20by%20mineralocorticoid-receptor-antagonism&rft.jtitle=Neuromuscular%20disorders%20:%20NMD&rft.au=Blain,%20A.M&rft.date=2009-09-01&rft.volume=19&rft.issue=8&rft.spage=581&rft.epage=582&rft.pages=581-582&rft.issn=0960-8966&rft.eissn=1873-2364&rft_id=info:doi/10.1016/j.nmd.2009.06.123&rft_dat=%3Cproquest_cross%3E20708704%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20708704&rft_id=info:pmid/&rft_els_id=1_s2_0_S0960896609002806&rfr_iscdi=true